Pharma Brands Benefit from “Mack Attacks” Say Attendees at DigiPharma EU
Last week I attended the DigiPharm EU conference in London and had a great time meeting old friends and people I have only interacted with through social media such as Twitter...
I am Off to London to Meet Some EU ePharma Pioneers at the DigiPharm...
I leave tonight to attend and speak at the 2nd annual DigiPharm Europe 2010 conference in London. I am looking forward to meeting a few people I learned about after I...
Avandia and Janet Woodcock, the Next FDA Commissioner
By now you all know about FDA's decision to put restrictions on how physicians prescribe Avandia in the US (see "FDA will significantly restrict the use of the diabetes drug Avandia")....
Did J&J Troll Social Media Sites to Ensure Its Motrin “Recall” was a Secret?
A Blog is a very useful archive of information that over time may reveal connections between seemingly unrelated events. Take the Johnson and Johnson (JNJ) "phantom recall" of Motrin that I...
LillyPad Launches Specious Rocket Attack Against Drug Price Control Straw Man
Eli Lilly, the drug company that increased the price of its antidepressant Cymbalta by 13.6% in 2009, is using its new corporate blog (LillyPad) as a launching site for defending high...
Are Secret Drug Recalls Common?
When Johnson and Johnson's McNeil Pharmaceuticals discovered that Motrin tablets on drugstore shelves might be faulty, the company hired contractors to purchase all the affected Motrin they could find in stores....
Online Behavioral Tracking Becomes More Sophisticated, Annoying — Soon Illegal?
A few months ago, I searched for and bought a futon on Overstock.com. For weeks afterward I kept seeing ads for Overstock.com futons pop up on almost every web site I...
J&J’s Goggins Takes Bullet for CEO Weldon
The New York Times reports that Colleen A. Goggins, who testified this spring before a Congressional committee investigating the recalls, will retire in March. Recall that I likened Googins testimony to...
Eli Lilly’s LillyPad Blog: To Whom Does It Speak?
Eli Lilly just joined the ranks -- more like single file -- of drug companies that have corporate blogs. Lilly calls their blog "LillyPad," a name that my Twitter pal Andrew...
Pharma, Facebook, and Inappropriate Ads
The following tweet from Boehringer Ingelheim (BI) was posted to the "News Direct from Drug Industry" forum on Pharma Marketing Network:
Boehringer: Thank you. RT @Pharmafocus: Digital Pharma: Boehringer gets social with...
